In advanced dry disease, a key problem is failure of retinal pigment epithelium, often shortened to RPE. These cells help ...

Companies across the globe are diligently working toward developing novel Dry Age Macular Degeneration treatment therapies ...

Scientists at USC are launching a new trial to test a tiny stem cell implant that could restore vision in people with ...

GlobalData is the parent company of Clinical Trials Arena. "Ocugen sets sights on Phase III after GA gene therapy win" was ...

Ocugen has reported preliminary phase 2 data on its eye disease gene therapy, providing more evidence that the candidate may ...

Two of Opus's seven gene therapy assets are in clinical trials, with additional programs expected to enter the clinic.

An editorial published today in The New England Journal of Medicine (NEJM) writes that Science Corporation's PRIMA implant is the first treatment in clinical trials to successfully restore functional ...

After unsheathing just a few months ago, Ollin Biosciences’ next-gen bispecific antibody cleared more disease faster than ...

RetinalGenix is developing a portfolio of non‑invasive imaging solutions, including a portable Retinal Imaging Screening Device and the RetinalCam remote monitoring system, designed for use without ...

Greenland sharks may have a DNA repair mechanism that maintains their vision for centuries, seemingly preventing retinal ...

Sanofi may rebid for Ocular Therapeutix, Inc. to boost retinal therapeutics ahead of Dupixent patent expiry. Click for more ...